Lamotrigine reduces intestinal I/R injury in the rat

Shock

Volumn 28, Issue 2, 2007, Pages 202-206

  Barut, Ibrahim ^a,b   Tarhan, Omer Ridvan ^a   Kapucuoglu, Nilgun ^a   Sutcu, Recep ^a   Akdeniz, Yusuf ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Catalase; Glutathione peroxidase; Intestinal ischemia; Lamotrigine; Malondialdehyde; Myeloperoxidase; Reperfusion injury; Superoxide dismutase

Indexed keywords

ANTICONVULSIVE AGENT; BIOLOGICAL MARKER; CATALASE; GLUTATHIONE PEROXIDASE; LAMOTRIGINE; LIPID; MALONALDEHYDE; MYELOPEROXIDASE; SCAVENGER; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME ACTIVITY; INTESTINE INJURY; INTESTINE ISCHEMIA; LIPID PEROXIDATION; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; RAT; TISSUE LEVEL; WISTAR RAT;

ANIMALS; ANTICONVULSANTS; INTESTINES; RATS; RATS, WISTAR; REPERFUSION INJURY; TRIAZINES;

EID: 34547672799     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e3180311dee     Document Type: Article

References (46)

1. Stefanutti G, Pierro A, Vinardi S, Spitz L, Eaton S: Moderate hypothermia protects against systemic oxidative stress in a rat model of intestinal ischemia and reperfusion injury. Shock 24:159-164, 2005.
2. Marzocco S, Di Paola R, Autore G, Mazzon E, Pinto A, Caputi AP, Thiemermann C, Cuzzocrea S: Calpain inhibitor I reduces intestinal ischemia-reperfusion injury in the rat. Shock 21:38-44, 2004.
3. Savas C, Aras T, Cakmak M, Bilgehan A, Ataoglu O, Turkozkan N, Ozguner F, Yucesan S, Dindar H: Pentoxifylline inhibits overflow and reduces intestinal reperfusion injury. J Pediatr Surg 32:905-910, 1997.
4. Schoenberg MH, Beger HG: Oxygen radicals in intestinal ischemia and reperfusion. Chem Biol Interact 76:141-161, 1990.
5. Schoenberg MH, Beger HG: Reperfusion injury after intestinal ischemia. Crit Care Med 21:1376-1386, 1993.
6. Sener G, Akgun U, Satiroglu H, Topaloglu U, Keyer-Uysal M: The effect of pentoxifylline on intestinal ischemia/reperfusion injury. Fundam Clin Pharmacol 15:19-22, 2001.
7. Otamiri T: Oxygen radicals, lipid peroxidation, and neutrophil infiltration after small-intestinal ischemia and reperfusion. Surgery 105:593-597, 1989.
8. Grisham MB, Hernandez LA, Granger DN: Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 251:G567-G574, 1986.
9. Kacmaz M, Ozturk HS, Karaayvaz M, Guven C, Durak I: Enzymatic antioxidant defence mechanism in rat intestinal tissue is changed after ischemia-reperfusion. Effects of an allopurinol plus antioxidant combination. Can J Surg 42:427-431, 1999.
10. Zimmerman BJ, Granger DN: Mechanisms of reperfusion injury. Am J Med Sci 307:284-292, 1994.
11. Deshmukh DR, Mirochnitchenko O, Ghole VS, Agnese D, Shah PC, Reddell M, Brolin RE, Inouye M: Intestinal ischemia and reperfusion injury in transgenic mice overexpressing copper-zinc superoxide dismutase. Am J Physiol 273:C1130-C1135, 1997.
12. Horton JW, White DJ: Free radical scavengers prevent intestinal ischemia-reperfusion-mediated cardiac dysfunction. J Surg Res 55:282-289, 1993.
13. Mullane KM, Kraemer R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 4:157-167, 1985.
14. Gutteridge JM, Halliwell B: The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15:129-135, 1990.
15. Cerqueira NF, Hussni CA, Yoshida WB: Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras 20:336-343, 2005.
16. Grace PA: Ischaemia-reperfusion injury. Br J Surg 81:637-647, 1994.
17. Marklund N, Clausen F, McIntosh TK, Hillered L: Free radical scavenger posttreatment improves functional and morphological outcome after fluid percussion injury in the rat. J Neurotrauma 18:821-832, 2001.
18. Yang Y, Li Q, Shuaib A: Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl- nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Exp Neurol 163:39-45, 2000.
19. Willmore LJ: Antiepileptic drugs and neuroprotection: current status and future roles. Epilepsy Behav 7:S25-S28, 2005.
20. Ataus SA, Onal MZ, Ozdem SS, Locke KW, Balkan S: The effects of citicoline and lamotrigine alone and in combination following permanent middle cerebral artery occlusion in rats. Int J Neurosci 114:183-196, 2004.
21. Calabresi P, Marti M, Picconi B, Saulle E, Costa C, Centonze D, Pisani F, Bernardi G: Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. Exp Neurol 182:461-469, 2003.
22. Balkan S, Ozben T, Balkan E, Oguz N, Serteser M, Gumuslu S: Effects of Lamotrigine on brain nitrite and cGMP levels during focal cerebral ischemia in rats. Acta Neurol Scand 95:140-146, 1997.
23. Bashkatova V, Narkevich V, Vitskova G, Vanin A: The influence of anticonvulsant and antioxidant drugs on nitric oxide level and lipid peroxidation in the rat brain during penthylenetetrazole-induced epileptiform model seizures. Prog Neuro-psychopharmacol Biol Psychiatry 27:487-492, 2003.
24. Afanas'ev I, Kudrin V, Rayevsky KS, Varga V, Saransaari P, Oja SS: Lamotrigine and carbamazepine affect differently the release of D-[3H]aspartate from mouse cerebral cortex slices: involvement of NO. Neurochem Res 24:1153-1159, 1999.
25. Hasan M, Lerman-Sagie T, Lev D, Watemberg N: Recurrent absence status epilepticus (spike-and-wave stupor) associated with lamotrigine therapy. J Child Neurol 21:807-809, 2006.
26. Consoni FT, Vital MA, Andreatini R: Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test. Eur Neuropsychopharmacol 16:451-458, 2006.
27. Ketter TA, Manji HK, Post RM: Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J Clin Psychopharmacol 23:484-495, 2003.
28. Megison SM, Horton JW, Chao H, Walker PB: A new model for intestinal ischemia in the rat. J Surg Res 49:168-173, 1990.
29. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN: Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101:478-483, 1970.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951.
31. Draper HH, Hadley M: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421-431, 1990.
32. Tetik C, Ozden A, Calli N, Bilgihan A, Bostanci B, Yis O, Bayramoglu H: Cytoprotective effect of trimetazidine on 60 minutes of intestinal ischemiareperfusion injury in rats. Transpl Int 12:108-112, 1999.
33. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169, 1967.
34. Aebi H: Catalase in vitro. Methods Enzymol 105:121-126, 1984.
35. Woolliams JA, Wiener G, Anderson PH, McMurray CH: Variation in the activities of glutathione peroxidase and superoxide dismutase and in the concentration of copper in the blood various breed crosses of sheep. Res Vet Sci 34:69-77, 1983.
36. Li XK, Suzuki H, Kimura T, Kawabe A, Uno T, Harada Y: Ulinastatin, a protease inhibitor, attenuates intestinal ischemia/reperfusion injury. Transplant Proc 26:2423-2425, 1994.
37. Hillegass LM, Griswold DE, Brickson B, Albrightson-Winslow C: Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 24:285-295, 1990.
38. Nilsson UA, Schoenberg MH, Aneman A, Poch B, Magadum S, Beger HG, Lundgren O: Free radicals and pathogenesis during ischemia and reperfusion of the cat small intestine. Gastroenterology 106:629-636, 1994.
39. Montalto MC, Hart ML, Jordan JE, Wada K, Stahl GL: Role for complement in mediating intestinal nitric oxide synthase-2 and superoxide dismutase expression. Am J Physiol Gasterointest Liver Physiol 285:G197-G206, 2003.
40. Gutteridge JM, Halliwell B: The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15:129-135, 1990.
41. Lee YS, Yoon BW, Roh JK: Neuroprotective effects of lamotrigine enhanced by flunarizine in gerbil global ischemia. Neurosci Lett 265:215-217, 1999.
42. Lee WT, Shen YZ, Chang C: Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy. Neuroscience 95:89-95, 2000.
43. Crumrine RC, Bergstrand K, Cooper AT, Faison WL, Cooper BR: Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest. Stroke 28:2230-2236, 1997.
44. Conroy BP, Black D, Lin CY, Jenkins LW, Crumrine RC, DeWitt DS, Johnston WE: Lamotrigine attenuates cortical glutamate release during global cerebral ischemia in pigs on cardiopulmonary bypass. Anesthesiology 90:844-854, 1999.
45. Hacioglu A, Algin C, Pasaoglu O, Pasaoglu E, Kanbak G: Protective effect of leptin against ischemia-reperfusion injury in the rat small intestine. BMC Gastroenterol 5:37, 2005.
46. Mallick IH, Yang WX, Winslet MC, Seifalian AM: Pyrrolidine dithiocarbamate reduces ischemia-reperfusion injury of the small intestine. World J Gastroenterol 11:7308-7313, 2005.